Biochemical relapse-free survival after high dose external radiotherapy (≥78Gy) and 6 months of androgen deprivation in high-risk localized prostate cancer patients

被引：0
|
作者：
Reuther, A
Reddy, C
Mahadevan, A
Kupelian, P
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] MD Anderson Orlando, Orlando, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.494
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2100
引用
收藏
页码：S289 / S290
页数：2
相关论文
共 50 条
  • [41] A Limited Course Of Androgen Deprivation And High Dose Targeted Radiotherapy Of Regional And/or Distant Oligometastatic Recurrences May Prolong Biochemical Free Survival In Prostate Cancer Patients
    Schick, U.
    Jorcano, S.
    Nouet, P.
    Rouzaud, M.
    Buchegger, F.
    Weber, D.
    Miralbell, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S445 - S446
  • [42] High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features
    Vargas, C.
    Martinez, A.
    Galalae, R.
    Demanes, J.
    Harsolia, A.
    Schour, L.
    Nuernberg, N.
    Gonzalez, J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 245 - 253
  • [43] Early biochemical predictors of survival in intermediate and high-risk prostate cancer treated with radiation and androgen deprivation therapy
    Patel, Mira A.
    Kollmeier, Marisa
    McBride, Sean
    Gorovets, Daniel
    Varghese, Melissa
    Chan, Luanna
    Knezevic, Andrea
    Zhang, Zhigang
    Zelefsky, Michael J.
    RADIOTHERAPY AND ONCOLOGY, 2019, 140 : 34 - 40
  • [44] Radiotherapy with androgen deprivation in high-risk prostate cancer: What outcomes on a Caribbean population?
    Kamwa, A. D. Foahom
    Vian, E.
    Agoua, G.
    Senechal, C.
    Bentaleb, Y.
    Fofana, M.
    Manip-M'Ebobisse, N.
    Blanchet, P.
    PROGRES EN UROLOGIE, 2012, 22 (15): : 954 - 962
  • [45] Whole Pelvis Irradiation Improves Biochemical Progression-free Survival in High-risk Prostate Cancer Patients Treated with External Beam Radiotherapy and High Dose Rate (HDR) Brachytherapy
    Tharmalingam, H.
    Tsang, Y.
    Kennedy, J.
    Choudhury, A.
    Hoskin, P.
    CLINICAL ONCOLOGY, 2018, 30 (03) : 195 - 195
  • [46] Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
    Saad, Akram
    Goldstein, Jeffrey
    Lawrence, Yaacov R.
    Spieler, Benjamin
    Leibowitz-Amit, Raya
    Berger, Raanan
    Davidson, Tima
    Urban, Damien
    Tsang, Lev
    Alezra, Dror
    Weiss, Ilana
    Symon, Zvi
    RADIATION ONCOLOGY, 2017, 12
  • [47] Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
    Akram Saad
    Jeffrey Goldstein
    Yaacov R. Lawrence
    Benjamin Spieler
    Raya Leibowitz-Amit
    Raanan Berger
    Tima Davidson
    Damien Urban
    Lev Tsang
    Dror Alezra
    Ilana Weiss
    Zvi Symon
    Radiation Oncology, 12
  • [48] Dose Escalated Hypofractionated Radiotherapy Improves Metastasis Free and Survival for High-intermediate and High-risk Prostate Cancer Patients
    Martinez, A. A.
    Ghilezan, M.
    Aloglah, L. M. A.
    Kernen, K.
    Gustafson, G.
    Ye, H.
    Krauss, D.
    Gonzalez, J.
    Vicini, F.
    Kestin, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S320 - S320
  • [49] Testosterone nadir and PSA recurrence-free survival in men with intermediate and high-risk localized prostate cancer undergoing definitive radiotherapy and androgen deprivation therapy.
    Alex, Bryant
    Mckay, Rana R.
    Kader, A. Karim
    Parsons, J. Kellogg
    Einck, John Paul
    Kane, Christopher J.
    Mundt, Arno James
    Murphy, James Don
    Rose, Brent Shane
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [50] Additional androgen deprivation makes the difference Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapy
    Schiffmann, Jonas
    Lesmana, Hans
    Tennstedt, Pierre
    Beyer, Burkhard
    Boehm, Katharina
    Platz, Volker
    Tilki, Derya
    Salomon, Georg
    Petersen, Cordula
    Kruell, Andreas
    Graefen, Markus
    Schwarz, Rudolf
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (04) : 330 - 337
12345